FDA's Top Drug Regulator Retiring

FDA's Top Drug Regulator Retiring

Update: 2025-12-02
Share

Description

Richard Pazdur, a top federal drug regulator, has reportedly submitted his retirement papers, planning to leave the Food and Drug Administration by the end of this month. He was a central figure, leading the agencys primary drug oversight division, the Center for Drug Evaluation and Research, or CDER. Pazdur was appointed to lead CDER in mid-November, a move that placed him at the helm of a crucial division. He is known for founding the FDAs Oncology Center of Excellence and was described as a regulatory innovator by FDA Commissioner Marty Makary.

The Daily News Now! - Every city. Every story. AI Powered.


Hosted on Acast. See acast.com/privacy for more information.

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

FDA's Top Drug Regulator Retiring

FDA's Top Drug Regulator Retiring